Advertisement
Loading...

Scancell Holdings plc

SCNLF•PNK
Healthcare
Biotechnology
$0.30
$0.07(32.89%)
U.S. Market is Open • 15:38

Scancell Holdings plc (SCNLF) Stock Overview

Explore Scancell Holdings plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap325.2M
P/E Ratio-43.99
EPS (TTM)$-0.01
ROE0.90%
Fundamental Analysis

AI Price Forecasts

1 Month$0.18
3 Months$0.21
1 Year Target$0.16

SCNLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Scancell Holdings plc (SCNLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 97.09, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.16.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -43.99 and a market capitalization of 325.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
37.46%
5-Day Change
37.46%
1-Month Change
120.70%
3-Month Change
62.55%
6-Month Change
132.15%
Year-to-Date (YTD) Change
117.64%
1-Year Change
84.57%
3-Year Change
42.45%
5-Year Change
-1.45%
All-Time (Max) Change
-30.36%

Contact Information

https://www.scancell.co.uk
44 18 6558 2066
Bellhouse Building, Oxford, NaN, OX4 4GD

Company Facts

61 Employees
IPO DateAug 2, 2013
CountryGB
Actively Trading

Frequently Asked Questions